The epigenetics of social adversity in early life: Implications for mental health outcomes

Neurobiology of Disease

Volumn 39, Issue 1, 2010, Pages 66-72

  McGowan, Patrick O ^a   Szyf, Moshe ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acetyltransferase; Adversity; Bipolar disorder; Childhood abuse; Chromatin; Demethylation; DNA methylation; DNMT; EGR1; Epigenetics; Gene environment interaction; Glucocorticoid; HDAC inhibitor; Hippocampus; Histone; Human brain; Maternal care; MeCP2; Mental health; Methionine; Neuron; NGFIA; Psychopathology; RETT syndrome; Ribosomal RNA; Rodent; RRNA; Schizophrenia; Stress; Suicide; TSA; Twin studies

Indexed keywords

DNA METHYLTRANSFERASE 3A; GLUCOCORTICOID RECEPTOR; HISTONE ACETYLTRANSFERASE; METHYL CPG BINDING PROTEIN 2; MICRORNA; VALPROIC ACID;

BIPOLAR DISORDER; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; EPIGENETICS; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC POLYMORPHISM; HUMAN; MENTAL HEALTH; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SUICIDE;

EPIGENESIS, GENETIC; HUMANS; MENTAL DISORDERS; PARENT-CHILD RELATIONS; SOCIAL CHANGE; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL;

EID: 77952887606     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.12.026     Document Type: Review

References (71)

1. Abdolmaleky H.M., Cheng K.H., Faraone S.V., Wilcox M., Glatt S.J., Gao F., et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 2006, 15:3132-3145.
2. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2 [see comments]. Nat. Genet. 1999, 23:185-188.
3. Basan, A., Leucht, S., 2004. Valproate for schizophrenia. Cochrane Database Syst. Rev. CD004028.
4. Beck S., Olek A., Walter J. From genomics to epigenomics: a loftier view of life. Nat. Biotechnol. 1999, 17:1144.
5. Ben Zeev Ghidoni B. Rett syndrome. Child Adolesc. Psychiatr. Clin. N. Am. 2007, 16:723-743.
6. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
7. Bergmann A., Lane M.E. HIDden targets of microRNAs for growth control. Trends Biochem. Sci. 2003, 28:461-463.
8. Bowden C.L. Spectrum of effectiveness of valproate in neuropsychiatry. Expert Rev. Neurother. 2007, 7:9-16.
9. Bredy T.W., Wu H., Crego C., Zellhoefer J., Sun Y.E., Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem. 2007, 14:268-276.
10. Bultman S.J., Gebuhr T.C., Magnuson T. A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development. Genes Dev. 2005, 19:2849-2861.
11. Chen Y., Sharma R.P., Cohen H., Klein E., Ben-Shachar D. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 2002, 30:2930-2939.
12. Chertkow-Deutsher Y., Sharma R.P., Costa R.H., Costa E., Grayson D.R. DNA methylation in vulnerability to post-traumatic stress in rats: evidence for the role of the post-synaptic density protein Dlgap2. Int. J. Neuropsychopharmacol. 2002, 1-13.
13. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., et al. REELIN and Schizophrenia: A Disease at the Interface of the Genome and the Epigenome. Mol. Interv. 2002, 2:47-57.
14. Costa E., Grayson D.R., Mitchell C.P., Tremolizzo L., Veldic M., Guidotti A. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit. Rev. Neurobiol. 2003, 15:121-142.
15. D'Alessio A.C., Szyf M. Epigenetic tete-a-tete: the bilateral relationship between chromatin modifications and DNA methylation. Biochem. Cell Biol. 2006, 84:463-476.
16. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10604-10609.
17. Fuchikami M., Morinobu S., Kurata A., Yamamoto S., Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int. J. Neuropsychopharmacol. 2009, 12:73-82.
18. Gibbons R.J., McDowell T.L., Raman S., O'Rourke D.M., Garrick D., Ayyub H., et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet. 2000, 24:368-371.
19. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., et al. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9341-9346.
20. Henikoff S., McKittrick E., Ahmad K. Epigenetics, histone H3 variants, and the inheritance of chromatin states. Cold Spring Harb. Symp. Quant. Biol. 2004, 69:235-243.
21. Herman G.E., Henninger N., Ratliff-Schaub K., Pastore M., Fitzgerald S., McBride K.L. Genetic testing in autism: how much is enough?. Genet. Med. 2007, 9:268-274.
22. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
23. Kaminsky Z.A., Tang T., Wang S.C., Ptak C., Oh G.H., Wong A.H., et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet. 2009, 41:240-245.
24. Kersh E.N., Fitzpatrick D.R., Murali-Krishna K., Shires J., Speck S.H., Boss J.M., et al. Rapid Demethylation of the IFN-{gamma} Gene Occurs in Memory but Not Naive CD8 T Cells. J. Immunol. 2006, 176:4083-4093.
25. Kuo M.H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 1998, 20:615-626.
26. Kuratomi G., Iwamoto K., Bundo M., Kusumi I., Kato N., Iwata N., et al. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry. 2008, 13:429-441.
27. Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001, 410:116-120.
28. Lasalle J.M. The Odyssey of MeCP2 and Parental Imprinting. Epigenetics. 2007, 2:5-10.
29. Lee D.Y., Hayes J.J., Pruss D., Wolffe A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 1993, 72:73-84.
30. Lee M.G., Wynder C., Schmidt D.M., McCafferty D.G., Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 2006, 13:563-567.
31. Lucarelli M., Fuso A., Strom R., Scarpa S. The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation. J. Biol. Chem. 2001, 276:7500-7506.
32. Mastroeni D., McKee A., Grover A., Rogers J., Coleman P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS ONE. 2009, 4:e6617.
33. Mattick J.S., Makunin I.V. Non-coding RNA. Hum. Mol. Genet. 2006, 15 Spec No 1:R17-R29.
34. McDonald P., Lewis M., Murphy B., O'Reilly R., Singh S.M. Appraisal of genetic and epigenetic congruity of a monozygotic twin pair discordant for schizophrenia. J. Med. Genet. 2003, 40:E16.
35. McGowan P.O., Kato T. Epigenetics in mood disorders. Environ. Health Prev. Med. 2008, 13:16-24.
36. McGowan P.O., Meaney M.J., Szyf M. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res. 2008, 1237:12-24.
37. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
38. McGowan P.O., Sasaki A., Huang T.C., Unterberger A., Suderman M., Ernst C., et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE. 2008, 3:e2085.
39. Meador K.J., Baker G.A., Browning N., Clayton-Smith J., Combs-Cantrell D.T., Cohen M., et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Engl. J. Med. 2009, 360:1597-1605.
40. Meaney M.J., Szyf M. Maternal care as a model for experience-dependent chromatin plasticity?. Trends Neurosci. 2005, 28:456-463.
41. Mehler M.F., Mattick J.S. Non-coding RNAs in the nervous system. J. Physiol. 2006, 575:333-341.
42. Mehler M.F., Mattick J.S. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol. Rev. 2007, 87:799-823.
43. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437:436-439.
44. Nagarajan R.P., Hogart A.R., Gwye Y., Martin M.R., Lasalle J.M. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics. 2006, 1:172-182.
45. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
46. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases [letter]. Nat. Genet. 1998, 19:219-220.
47. Perry M., Chalkley R. Histone acetylation increases the solubility of chromatin and occurs sequentially over most of the chromatin. A novel model for the biological role of histone acetylation. J. Biol. Chem. 1982, 257:7336-7347.
48. Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet. 2006, 22:347-350.
49. Petronis A., Gottesman I.I., Kan P., Kennedy J.L., Basile V.S., Paterson A.D., et al. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?. Schizophr. Bull. 2003, 29:169-178.
50. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001, 276:36734-36741.
51. Picketts D.J., Higgs D.R., Bachoo S., Blake D.J., Quarrell O.W., Gibbons R.J. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum. Mol. Genet. 1996, 5:1899-1907.
52. Qureshi I.A., Mehler M.F. Regulation of non-coding RNA networks in the nervous system-what's the REST of the story?. Neurosci. Lett. 2009, 466:73-80.
53. Ramchandani S., Bhattacharya S.K., Cervoni N., Szyf M. DNA methylation is a reversible biological signal. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6107-6112.
54. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. Embo. J. 1998, 17:4905-4908.
55. Razin A., Cedar H. Distribution of 5-methylcytosine in chromatin. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:2725-2728.
56. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
57. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 2006, 75:243-269.
58. Simonini M.V., Camargo L.M., Dong E., Maloku E., Veldic M., Costa E., et al. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1587-1592.
59. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9:465-476.
60. Szyf M. Towards a pharmacology of DNA methylation. Trends Pharmacol. Sci. 2001, 22:350-354.
61. Szyf M. The early life environment and the epigenome. Biochim. Biophys. Acta. 2009, 1790:878-885.
62. Tsankova N., Renthal W., Kumar A., Nestler E.J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8:355-367.
63. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9:519-525.
64. Tsujita T., Niikawa N., Yamashita H., Imamura A., Hamada A., Nakane Y., et al. Genomic discordance between monozygotic twins discordant for schizophrenia. Am. J. Psychiatry. 1998, 155:422-424.
65. Tsukada Y., Fang J., Erdjument-Bromage H., Warren M.E., Borchers C.H., Tempst P., et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006, 439:811-816.
66. Veldic M., Kadriu B., Maloku E., Agis-Balboa R.C., Guidotti A., Davis J.M., et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr. Res. 2007, 91:51-61.
67. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16426-16431.
68. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
69. Yoshimura R., Shinkai K., Ueda N., Nakamura J. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients. Pharmacopsychiatry. 2007, 40:9-13.
70. Zhu J.K. Epigenome sequencing comes of age. Cell 2008, 133:395-397.
71. Zilberman D., Gehring M., Tran R.K., Ballinger T., Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat. Genet. 2007, 39:61-69.